Education
About Us
Working with TipRanks
Follow Us
China Health Group Inc. (HK:8225)
:8225
8225 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.10 - HK$0.24
Previous CloseN/A
Volume40.00K
Average Volume (3M)288.00K
Market Cap
€183.14M
Enterprise ValueHK$134.68M
Total Cash (Recent Filing)€15.89M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding995,351,700
10 Day Avg. Volume514,000
30 Day Avg. Volume288,000
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8225 FAQ
What was China Health Group Inc.’s price range in the past 12 months?
China Health Group Inc. lowest stock price was HK$0.10 and its highest was HK$0.24 in the past 12 months.
What is China Health Group Inc.’s market cap?
China Health Group Inc.’s market cap is €183.14M.
When is China Health Group Inc.’s upcoming earnings report date?
China Health Group Inc.’s upcoming earnings report date is Nov 12, 2025 which is in 42 days.
How were China Health Group Inc.’s earnings last quarter?
China Health Group Inc. released its earnings results on Aug 25, 2025. The company reported HK$0.009 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.009.
Is China Health Group Inc. overvalued?
According to Wall Street analysts China Health Group Inc.’s price is currently Overvalued.
Does China Health Group Inc. pay dividends?
China Health Group Inc. does not currently pay dividends.
What is China Health Group Inc.’s EPS estimate?
China Health Group Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Inc. have?
China Health Group Inc. has 995,351,700 shares outstanding.
What happened to China Health Group Inc.’s price movement after its last earnings report?
China Health Group Inc. reported an EPS of HK$0.009 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.778%.
Which hedge fund is a major shareholder of China Health Group Inc.?
Currently, no hedge funds are holding shares in HK:8225
Company Description
China Health Group Inc.
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Technical Analysis
Life Healthcare Group
―
Meihao Medical Group Co., Ltd.
―
Mediwelcome Healthcare Management & Technology Inc.
―
Bamboos Health Care Holdings Ltd
―
Huakang Biomedical Holdings Company Limited
―